These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 39350242)

  • 1. Beyond the numbers: reimagining healing with psychedelics for eating disorders.
    Lafrance A; Spriggs MJ; Gukasyan N; Peck SK
    J Eat Disord; 2024 Sep; 12(1):148. PubMed ID: 39350242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms.
    Calder A; Mock S; Friedli N; Pasi P; Hasler G
    Eur Neuropsychopharmacol; 2023 Oct; 75():1-14. PubMed ID: 37352816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery.
    VanderZwaag B; Garcia-Romeu A; Garcia-Barrera MA
    Ther Adv Psychopharmacol; 2024; 14():20451253241264812. PubMed ID: 39132012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science.
    Adams DR; Allen H; Nicol GE; Cabassa LJ
    Transl Behav Med; 2024 Nov; 14(12):744-752. PubMed ID: 39419768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychedelic-Assisted Therapy for People with Eating Disorders.
    Gukasyan N; Schreyer CC; Griffiths RR; Guarda AS
    Curr Psychiatry Rep; 2022 Dec; 24(12):767-775. PubMed ID: 36374357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence.
    Koning E; Brietzke E
    Trends Psychiatry Psychother; 2024; 46():e20220597. PubMed ID: 37126863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.
    Foldi CJ; Liknaitzky P; Williams M; Oldfield BJ
    Front Neurosci; 2020; 14():43. PubMed ID: 32116500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.
    Foldi CJ; Liknaitzky P; Williams M; Oldfield BJ
    Focus (Am Psychiatr Publ); 2024 Jul; 22(3):373-380. PubMed ID: 38988467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder.
    Spriggs MJ; Kettner H; Carhart-Harris RL
    Eat Weight Disord; 2021 May; 26(4):1265-1270. PubMed ID: 32895801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.
    Kelly DF; Heinzerling K; Sharma A; Gowrinathan S; Sergi K; Mallari RJ
    Neurosurgery; 2023 Apr; 92(4):680-694. PubMed ID: 36512813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives and preliminary experiences of psychedelics for the treatment of eating disorders: A systematic scoping review.
    Cuerva K; Spirou D; Cuerva A; Delaquis C; Raman J
    Eur Eat Disord Rev; 2024 Sep; 32(5):980-1001. PubMed ID: 38783636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "But the reality is it's happening": A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy.
    Downey AE; Boyd M; Chaphekar AV; Woolley J; Raymond-Flesch M
    Int J Eat Disord; 2023 Nov; 56(11):2142-2148. PubMed ID: 37551650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The psychedelic effects of cannabis: A review of the literature.
    Wolinsky D; Barrett FS; Vandrey R
    J Psychopharmacol; 2024 Jan; 38(1):49-55. PubMed ID: 37947321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research into Psychedelic-Assisted Psychotherapy for Anorexia Nervosa Should be Funded.
    Otterman LS
    J Bioeth Inq; 2023 Mar; 20(1):31-39. PubMed ID: 36534233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical considerations for psychedelic-assisted therapy in military clinical settings.
    Hoener S; Wolfgang A; Nissan D; Howe E
    J Med Ethics; 2024 Mar; 50(4):258-262. PubMed ID: 37253556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychedelics and virtual reality: parallels and applications.
    Aday JS; Davoli CC; Bloesch EK
    Ther Adv Psychopharmacol; 2020; 10():2045125320948356. PubMed ID: 32922734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".
    Spriggs MJ; Douglass HM; Park RJ; Read T; Danby JL; de Magalhães FJC; Alderton KL; Williams TM; Blemings A; Lafrance A; Nicholls DE; Erritzoe D; Nutt DJ; Carhart-Harris RL
    Front Psychiatry; 2021; 12():735523. PubMed ID: 34744825
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychedelia: The interplay of music and psychedelics.
    Jerotic K; Vuust P; Kringelbach ML
    Ann N Y Acad Sci; 2024 Jan; 1531(1):12-28. PubMed ID: 37983198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia.
    Nadeem Z; Parker S; McGovern H; Oestreich LK
    Aust N Z J Psychiatry; 2024 Oct; 58(10):904-913. PubMed ID: 38907608
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.